XPRIZE
31.5.2019 21:28:12 CEST | Business Wire | Press release
Today, XPRIZE , the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, has announced winners in the $7M Shell Ocean Discovery XPRIZE , a global competition to advance ocean technologies for rapid, unmanned and high-resolution ocean exploration and discovery.
The results were revealed at an awards ceremony hosted at the world-renowned Oceanographic Museum of Monaco, part of the Oceanographic Institute, Prince Albert I of Monaco Foundation. The grand prize winner, receiving a total of $4M, was GEBCO-NF Alumni , an international team based in the United States, while KUROSHIO , from Japan, claimed $1M as the runner-up:
- GEBCO-NF (International) – Led by Rochelle Wigley, Ph.D. and Yulia Zarayskaya, Ph.D., the 14-nation team integrated existing technologies and ocean-mapping experience with a robust and low-cost unmanned surface vessel, the SeaKIT, along with a novel cloud-based data processing system that allows for rapid seabed visualization, to contribute towards comprehensive mapping of the ocean floor by 2030.
- KUROSHIO (Yokosuka, Japan) – Led by Takeshi Nakatani, Ph.D., the team integrated technologies from their partners to create a surface vessel and software platform that can operate with different autonomous underwater vessels, which increases the versatility of their technology.
The $1M National Oceanic and Atmospheric Administration (NOAA) Bonus Prize for teams to develop technology that could detect a chemical or biological signal underwater and autonomously track it to its source was split between junior high school team Ocean Quest from San Jose, California, claiming $800K as the winner, and Tampa Deep Sea Xplorers , from Florida, taking $200K as runner-up.
“Currently, more than 80 percent of the world’s ocean is unmapped, and I'm proud to have worked alongside the people who will change this as a part of this XPRIZE,” said Executive Director of the Ocean Discovery XPRIZE, Jyotika Virmani, Ph.D. “Our vision is that these new technologies will enable the discovery of new ocean species, underwater resources, geological features, and safer methods of exploring the deep sea, while illuminating the mysteries of the deep and discovering what has remained unknown since the dawn of time.”
Additionally, the judges unanimously recommended a $200K “Moonshot Award” for Team Tao from the United Kingdom for its unique approach to seafloor mapping, even though they did not meet the criteria of the competition.
“The Ocean Discovery XPRIZE teams' accomplishments are a true reflection of XPRIZE’s core belief that incentivizing the crowd will drive innovation and investment, leading to a massive shift in the state of the market,” said Anousheh Ansari, CEO of XPRIZE. “It is an honor to celebrate the winning teams GEBCO-NF Alumni, KUROSHIO, Ocean Quest, Tampa Deep Sea Xplorers, as well as Team Tao for their unprecedented, radical approach. We look forward to watching these pioneers shape the future of ocean exploration and discovery.”
To determine winners, the panel of independent judges reviewed data from field testing conducted in Kalamata, Greece and Ponce, Puerto Rico. In Kalamata, teams had up to 24 hours to map at least 250 km2 of the ocean seafloor at 5m horizontal resolution or higher. The gold-standard high-resolution baseline maps, against which the team maps were judged, were provided by Ocean Infinity and Fugro, while Esri, the global leader in geographic information system (GIS) software and geodatabase management, donated its award-winning ArcGIS Online platform for the teams and judges to use.
“At Shell, we are firm believers in the power of ideas and the value of collaboration to solve big problems,” said Martin Stauble, Shell’s Vice President Exploration North America and Brazil. “We are proud to be part of the Shell Ocean Discovery XPRIZE. This prize energized teams from across the globe and stimulated innovation, technology and learning, all in support of providing data for a better understanding of our oceans. We hope that the XPRIZE results will be a catalyst to create a step-change in the speed and quality of data that companies, research institutes and society can use.”
As part of the total $7M prize purse, four teams opted to compete for the $1M NOAA Bonus Prize. In a field test in Ponce, Puerto Rico, teams needed to demonstrate that their technology can “sniff out” a specified object in the ocean by first detecting and then tracing a biological or chemical signal to its source. The judges determined that no single team was able to trace the signal to its source in the timeframe allowed, so the prize was divided among the two teams that came the closest.
Last year, nine finalist teams were awarded an equal share of the first $1M of the $7M prize purse, in recognition of their progress-to-date and to support the teams’ continued technological development.
“NOAA is proud to support this important competition that is accelerating the development of new unmanned tools capable of tracking chemical and biological signals in our ocean,” said Neil Jacobs, Ph.D., acting NOAA administrator. “The cutting-edge technologies that have emerged as a result of the NOAA Bonus Prize will help fuel a growing Blue Economy and inspire future innovation.”
As part of its post-prize impact work, XPRIZE announced a partnership with Seabed 2030, a collaborative project between The Nippon Foundation and The General Bathymetric Chart of the Oceans (GEBCO) to inspire the complete mapping of the world’s ocean by 2030 and to compile all bathymetric data into the freely-available GEBCO Ocean Map.
Additionally, and in anticipation of World Oceans Day on June 8th, XPRIZE will launch a science fiction ocean anthology featuring 19 original short stories and artwork set in a future when technology has helped unlock the secrets of the world’s oceans.
For more information, visit oceandiscovery.xprize.org .
About XPRIZE
XPRIZE designs and operates multi-million-dollar, global competitions to incentivize the development of technological breakthroughs that accelerate humanity toward a better future. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million ANA Avatar XPRIZE and the $5 Million IBM Watson AI XPRIZE. For more information, visit xprize.org .
About Royal Dutch Shell
Shell has been a technology pioneer for more than 100 years, and has come up with many industry-transforming “firsts” to deliver energy its customers and partners need. Since 2007, Shell has spent more than $1 billion annually on research and development. In 2014, our research and development expenditures were $1.2 billion. Shell’s technical and engineering staff amount to more than 43,000.
Shell companies have operations in more than 70 countries and territories with businesses including oil and gas exploration and production; production and marketing of liquefied natural gas and gas to liquids; manufacturing, marketing and shipping of oil products and chemicals and renewable energy projects. Royal Dutch Shell plc is incorporated in England and Wales, has its headquarters in The Hague and is listed on the London, Amsterdam, and New York stock exchanges. For further information, visit www.shell.com .
About National Oceanic and Atmospheric Administration (NOAA)
The National Oceanic and Atmospheric Administration (NOAA) is a science-based federal agency within the Department of Commerce with regulatory, operational and information service responsibilities with a presence in every state and U.S. territories. NOAA's mission is to understand and predict changes in the Earth's environment, from the depths of the ocean to the surface of the sun, and to conserve and manage coastal and marine resources. For more information, visit www.noaa.gov .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005539/en/
Contact:
Eric Desatnik & Katherine Schelbert 310.741.4880 / eric@xprize.org katherine.schelbert@xprize.org
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
